YH25448

· Yuhan Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YH25448, covering 2025-03-21 to 2025-03-21. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of YH25448 in Patients with EGFR Mutation Positive Advanced NSCLC [Phase 1, Phase 2]